Patent · US Expired

pp: A newly identified CD45-associated protein

US5510461A · kind A · utility

1Cited by

0References

4Claims

0Family size

Assignee

BASF SE

Inventors

Stefan Meuer · Worms, DE
Burkhart Schraven · Ladenburg, DE
David Schoenhaut · Clifton, US
Sheldon Ratnofsky · Newton, US

Key dates

Filing date	Feb 14, 1994
Grant date	Apr 23, 1996
Priority date	—
Expiry date	Feb 14, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a newly identified protein useful for treating diseases of the immune system, methods for obtaining said protein, isolated nucleic acids encoding said protein, and methods for obtaining inhibitors of said protein. The protein of this invention is characterized by an apparent molecular weight of about 32 kD, an isoelectric point of about 4.0-4.5 and coprecipitation with CD45. The protein may also be used in in vitro or in vivo assays to identify inhibitors of T cell activation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.